ProQR Therapeutics N.V. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.28 |
Market Cap |
$358.8 M |
Shares Outstanding |
38.87 M |
Public Float |
27.49 M |
Address |
Zernikedreef 9 Leiden Zuid-Holland 2333 CK Netherlands |
Employees | - |
Website | http://www.proqr.com |
Updated | 07/08/2019 |
ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands. |